Skip to main content
drug protocol number
MN39159
drug sponsor
Roche
drug study
Ocrelizumab
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh)
drug status
Terminated
drug phase